TrumpRx.gov has launched as a new US drug pricing platform, outlining federal policy goals, pricing benchmarks, and industry participation aimed at improving prescription drug affordability.
Written By: Pharmacally Medical News Desk
President Donald J. Trump launched TrumpRx.gov on February 5, 2026, as a key part of his healthcare initiative to drastically cut prescription drug prices for Americans. The site implements “Most-Favored-Nation” pricing, matching U.S. costs to the lowest global rates and offering direct-to-consumer discounts up to 93% on high-cost medications.
Launch Background
Trump first announced TrumpRx in September 2025 alongside a Pfizer deal, with the site delayed from January to February 2026. Health and Human Services Secretary Robert F. Kennedy Jr. confirmed readiness days before the rollout. The platform fulfills Trump’s pledge to end “international price exploitation,” prioritizing U.S. patients over global subsidies.
Key Price Reductions
Major discounts target diabetes, obesity, heart disease, and respiratory drugs.
- Ozempic drops from $1,028 to $350 monthly.
- Wegovy (injectable) from $1,349 to $199; pill version to $149.
- Inhalers like Bevespi Aerosphere fall from $458 to $51, Airsupra from $504 to $201
Drug | Original Price (Monthly) | TrumpRx Price | Savings % |
Ozempic | $1,028 | $350 | ~66% |
Wegovy Pen | $1,349 | $199 | ~85% |
Wegovy Pill | $1,349 | $149 | ~89% |
Zepbound | $1,087 | $299 | ~72% |
Gonal-F (450IU) | $1,449 | $99 | 93% |
Prices shown are based on TrumpRx listings and may vary by eligibility, pharmacy, or manufacturer participation
Pfizer Partnership
Pfizer launched discounts on over 30 drugs via TrumpRx, averaging 50% off list prices and up to 85% for self-pay patients. CEO Albert Bourla highlighted affordability for conditions like migraines, arthritis, and menopause while boosting U.S. manufacturing. The deal suspends certain import tariffs for three years.
How It Works
Users visit TrumpRx.gov to compare prices, access coupons via GoodRx, or opt for at-home delivery at U.S. pharmacies. It covers uninsured or self-pay insured patients, with 16+ drugmakers signed on. HHS guidance cleared direct manufacturer sales.
Broader Impact
The site supports Trump’s “Great Healthcare Plan,” promising 80-90% cuts on many drugs and lower insurance premiums. Over 100 million patients could benefit, strengthening U.S. pharma innovation. Negotiations continue with more firms.
References
Fact Sheet: President Donald J. Trump Launches TrumpRx.gov to Bring Lower Drug Prices to American Patients, 05 February 2026, https://www.whitehouse.gov/fact-sheets/2026/02/fact-sheet-president-donald-j-trump-launches-trumprx-gov-to-bring-lower-drug-prices-to-american-patients/
President Trump Unveils the Great Healthcare Plan to Lower Costs and Deliver Money Directly to the People, 15 January 2026, https://www.whitehouse.gov/articles/2026/01/president-trump-unveils-the-great-healthcare-plan-to-lower-costs-and-deliver-money-directly-to-the-people/
Trump announces ‘TrumpRx’ site for discounted drugs and deal with Pfizer to lower prices, 01 October 2025, https://edition.cnn.com/2025/09/30/politics/pfizer-drug-prices-trump
HHS Clears Path for Lower-Cost Prescription Drugs Through Direct-to-Consumer Programs, 27 January 2026, https://www.hhs.gov/press-room/oig-clears-path-for-lower-cost-prescription-drugs.html